• Patent Title: LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
  • Application No.: US15752072
    Application Date: 2016-09-22
  • Publication No.: US11643687B2
    Publication Date: 2023-05-09
  • Inventor: Sven Olek
  • Applicant: Precision for Medicine GmbH
  • Applicant Address: DE Berlin
  • Assignee: Precision for Medicine GmbH
  • Current Assignee: Precision for Medicine GmbH
  • Current Assignee Address: DE Berlin
  • Priority: GB 16972 2015.09.25
  • International Application: PCT/EP2016/072579 2016.09.22
  • International Announcement: WO2017/050916A 2017.03.30
  • Date entered country: 2018-02-12
  • Main IPC: C12Q1/6881
  • IPC: C12Q1/6881
LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
Abstract:
The present invention relates to a method, in particular an in vitro method, for identifying B cells, comprising analyzing the methylation status of at least one CpG position in the mammalian gene region for Low density lipoprotein receptor-related protein 5 (LRP5), wherein a demethylation or lack of methylation of said gene region is indicative for a B cell, when compared to a non-B cell. The analyses according to the invention can identify B cells on an epi-genetic level and distinguish them from all other cells in complex samples, such as, for example, other blood or immune cells. The present invention furthermore provides an improved method for quantifying B cells, in particular in complex samples. The method can be performed without a step of purifying and/or enriching cells, preferably in whole blood and/or non-trypsinized tissue. Further claimed are kits and specific primers and probes for identifying methylation.
Information query
Patent Agency Ranking
0/0